Two different shRNAs targeting the ZRF1 coding region were transduced in six different neuroblastoma cell lines and showed a marked reduction in ZRF1 levels compared to non-silencing control (NSC)-transduced cells (Figure 5a and Figure S4A). This evidence concerns the gene DNAJC2 and neuroblastoma.